Surgimart Surgical India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-07-2024
- Paid Up Capital ₹ 0.10 M
as on 01-07-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2021)
- Profit -451.06%
(FY 2021)
- Ebitda -465.04%
(FY 2021)
- Net Worth -69.19%
(FY 2021)
- Total Assets 268.87%
(FY 2021)
About Surgimart Surgical India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Girijesh Singh and Amrendra Singh serve as directors at the Company.
- CIN/LLPIN
U74999UP2017PTC088830
- Company No.
088830
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gorakhpur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Surgimart Surgical India Private Limited offer?
Surgimart Surgical India Private Limited offers a wide range of products and services, including Medical & Surgical Clothing, Medical Pads, Bed Linen & Bedspreads, Bed Sheets, Face Mask & Medical PPE Kits, Medical Caps, Personal Protective Equipment, OT Linen, Face Mask, Disposable Gloves.
Who are the key members and board of directors at Surgimart Surgical India?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Girijesh Singh | Director | 02-Jan-2017 | Current |
Amrendra Singh | Director | 02-Jan-2017 | Current |
Financial Performance of Surgimart Surgical India.
Surgimart Surgical India Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 451.06% decrease in profit. The company's net worth observed a substantial decline by a decrease of 69.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Surgimart Surgical India?
In 2021, Surgimart Surgical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Surgimart Surgical India?
Unlock and access historical data on people associated with Surgimart Surgical India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surgimart Surgical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surgimart Surgical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.